分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

提高排除风险的能力，降低企业的运行和合规风险，本单位定于 2020 年 11 月 13 日至 15 日在杭州市举办「2020 研制和生产现场检查要点及实例剖析培训班」，邀请业内权威专家针对相关问题进行深入解析。一、会议安排 会议地点：杭州市（具体地点通知给已报名人员）会议时间：2020 年 11 月 13 日-15 日

2021 年 4 月 13 日，重庆复创医药研究有限公司（以下简称「复创医药」）自主研发的选择性 TRK 抑制剂 FCN-011 胶囊的 I 期临床研究在复旦大学附属肿瘤医院完成首例受试者给药。该研究是一项多中心、开放、单臂 I 期剂量探索和 II 期扩展研究，评价 FCN-011 在晚期实体瘤（I 期

液每 0.1 mL 含 250U；破伤风抗毒素每 0.1 mL 含 15U；细胞色素 C 每 0.1 mL 含 0.075 mg。6. 记出入液量的意义？答：(1...，胆囊颈管收缩，易产生胆绞痛。另外夜间平卧，特别是右侧卧时，胆石易自胆囊滑进胆囊颈管，发生嵌顿，引起胆绞痛。13. 搬运内脏出血的病人应注意什么？答：内脏出血最常见的

分类A：强烈推荐I：证据来自随机对照研究B：常规推荐II：证据来自非随机试验C：次级推荐III：仅为专家意见D：不推荐1. 出现哪些临床表现需怀疑脑炎？推荐意见：（1）近期出现的发热伴行为、认知、性格或意识改变，或癫痫发作，或局灶性神经功能缺损症状或体征，需考虑脑炎的可能，应选择合适的检查手段（A，II）；（2）如亚急性

第13届亚太临床微生物暨感染病会议尊敬的各位同仁： 非常荣幸邀请大家出席“第13届亚太临床微生物暨感染病会议”（13th APCCMI，原“西太平洋感染与化疗会议”

-11治疗目的与降血压目标-12治疗策略-13用药原则-14高血压病...ACEI-23受体阻滞剂-24血管紧张素II受体阻滞剂-25

。六、报名方式：请于10 月10 日前以电话、信息或邮件方式报名，以便会务安排。七、授予学分：Ⅰ类教育学分6分、II类学分6分，请备华医网IC卡...车（华润万家对面，中国联通旁）。2、公交线路：可乘坐BRT 线路B1、B2、B3、B4、B5、B6、B7、B11、B12、B13、B16、B17、B20

休息与活动指导-28饮食护理-30有症状MM或D-S分期II期以上患者的治疗-13有症状MM或D-S分期II期以上患者的治疗-14有症状MM或D-S分期II期以上患者的治疗-15

心衰合并房颤-41预防AF程序I-25预防AF程序II-26预防AF程序II-28预防AF程序II-27预防AF程序III-29

中国生物医学工程学会在北京举办“第13期全国关节镜临床手术操作学习班”。参加学习者将授予国家级I类医学继续教育学分。现将有关事项通知如下： 前12期已参加学员对学习班的评价：收获很大、没有白来！一、课程内容介绍1、老师讲解示范膝关节

背景介绍：CRISPR/Cas9 是细菌和古细菌在长期选择压力中形成的一种适应性免疫防御，可用来有效抵御病毒及外源DNA的入侵。CRISPR的Type II已经被广泛用于基因工程，它包含Cas9，crRNA和tracrRNA，其中crRNA含有能够识别20bp的靶向互补序列。Cas9，crRNA和tracrRNA组成

在您的支持和关注中，连续举办12年的呼吸支持技术高级研修班，厚积薄发迈入第13个年头！继续由詹庆元教授牵头组织、北京朝阳医院/中日友好医院第13届呼吸支持技术高级研修班将于2013年8月23日—26日在北京隆重举办。届时，星光熠熠的明星专家团队将为您奉上呼吸支持技术及ICU重症感染

发表了一篇论文称，一项随机双盲安慰剂对照II期研究表明，复发性卵巢癌 AMG 386联合紫杉醇周疗可耐受，且安全性可控。AMG 386是一种肽-fc...值得进一步研究。文献原文：Randomized, Double-Blind, Placebo-Controlled Phase II Study

据英国《每日邮报》8月26日报道，以色列一项最新研究发现，吃葡萄柚有助于治疗糖尿病。科学家表示，葡萄柚之所以带有苦味，是因为其中含有抗氧化剂柚苷配基。新研究发现，柚苷配基对II型糖尿病的治疗作用可以与目前广泛使用的两种2型糖尿病药物相媲美，治疗效果难分伯仲。当人体

;—第一届“专科临床药师药学服务技能国际论坛” （项目编号：2012-13-01-040 (国)）。一、会议主要内容

「饶主任，您是我家的恩人，没有您的团队，小涛的命根子就难保住了。」 小涛的父母看到小涛顺畅而有力的正常排尿，激动地说道。近日，13 岁男童因玩耍致尿道断裂，江西省儿童医院泌尿外科团队为其紧急手术修复。事情要从 7 月 8 日说起，江西吉安 13 岁 5 个月的小涛（化名），天性顽皮，和同伴比赛爬杆，一不小心从高

「长高 13 cm」，带着萧山中医院送的这份「健康大礼」，来自贵州从江的小田高高兴兴地回了老家。在出院前，她开心地说：「做梦都没想到，这是我收到最好的新年礼物...手术治疗，如今的小田不仅在形象上有了质的改变，身高从 127 cm 长到了 140 cm，整整增高了 13 cm，而且心肺功能和胃肠道功能也都得到了很大

上，系统地介绍了脑干不同部位手术的安全操作区（13 个）及手术入路（10 种）的选择。13 个手术安全操作区1. 中脑（1）中脑前区中脑前区的病变可以经大脑脚...大部分颞骨。在颧弓根部上钻孔，骨窗大小以个体疾病而定；U 型剪开硬脑膜，在颞叶底部进行分离，直至天幕缘；确认天幕缘的中前切迹，打开环池、脚间池的蛛网膜。这样即可